Exact Sciences(EXAS)
Search documents
Exact Sciences(EXAS) - 2022 Q2 - Earnings Call Transcript
2022-08-02 23:16
Exact Sciences Corporation (NASDAQ:EXAS) Q2 2022 Earnings Conference Call August 2, 2022 5:00 PM ET Company Participants Megan Jones - Senior Director, Investor Relations Kevin Conroy - Chairman & Chief Executive Officer Jeff Elliott - Chief Financial Officer & Chief Operating Officer Everett Cunningham - Chief Commercial Officer Conference Call Participants Derik De Bruin - Bank of America Brandon Couillard - Jefferies Brian Weinstein - William Blair Catherine Schulte - Baird Dan Brennan - Cowen Vijay Kum ...
Exact Sciences(EXAS) - 2022 Q1 - Earnings Call Transcript
2022-04-27 01:34
Exact Sciences Corporation (NASDAQ:EXAS) Q1 2022 Earnings Conference Call April 26, 2022 5:00 PM ET Company Participants Megan Jones - Senior Director of IR Kevin Conroy - Chairman and CEO Jeff Elliott - CFO and COO Everett Cunningham - Chief Commercial Officer Conference Call Participants Brian Weinstein - William Blair Derik De Bruin - Bank of America Merrill Lynch Catherine Schulte - Baird Brandon Couillard - Jefferies Matt Sykes - Goldman Sachs Dan Arias - Stifel Dan Brennan - Cowen Vijay Kumar - ...
Exact Sciences(EXAS) - 2021 Q4 - Earnings Call Transcript
2022-02-23 02:50
Exact Sciences Corporation (NASDAQ:EXAS) Q4 2021 Earnings Conference Call February 22, 2022 5:00 PM ET Company Participants Megan Jones - Senior Director, Investor Relations Kevin Conroy - Chairman and Chief Executive Officer Jeff Elliott - Chief Financial Officer and Chief Operating Officer Conference Call Participants Matt Sykes - Goldman Sachs Brandon Couillard - Jefferies Derik De Bruin - Bank of America Brian Weinstein - William Blair Vijay Kumar - Evercore Catherine Schulte - Baird Dan Brennan - Cowen ...
Exact Sciences(EXAS) - 2021 Q4 - Annual Report
2022-02-21 16:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________________________ FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended: December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-35092 | --- | --- | --- | |--------------------------------------------------------- ...